BioCentriq™ is the Cell and Gene Therapy Development and Manufacturing Center and Center of Excellence at NJII.
We have a state-of-the-art process development and cGMP manufacturing center equipped with two GMP suites for cell & gene therapy clinical production and a cell & gene therapy process development pilot plant.
BioCentriq™ has been designed to support the development of cell and gene therapies through innovation and collaboration.
Our clients choose us because we offer fast and cost effective development services that are secure, confidential and flexible. To learn more about the Biopharma Division, click here.
Services We Provide
Flexible Manufacturing
BioCentriq™ is available for pre-competitive group sponsored projects and fee-for-service proprietary projects.
We enable rapid growth of new scale-up and manufacturing technologies, customized as needed for each client.
Client teams are welcome to join our staff during project work to facilitate knowledge transfer in a hybrid "hoteling" model. We also have the expertise required to run your projects for you.
Most importantly, we do not retain any intellectual property, all IP belongs solely to you, the client.
Solutions for Cell & Gene Therapies
Narrowing the Skills Gap
We collaborate with large pharmaceutical companies, training partners and funders such as the US government and the National Institute for Innovation in Manufacturing (NIIMBL).
Our goal is to educate the next generation workforce who want to provide general and customized training in cell therapy and biologics manufacturing.
Our Industry Partners
Meet The Team
Haro
Hartounian, Ph.D.
Senior Vice President & General Manager
Hanna
Ioannidis, Ph.D.
Director, Alliance & Project Management
Chathuranga
De Silva, Ph.D.
Director, Business Development
Sadiq
Khan, MBA
Senior Director, Planning & Operations
Fuhua
Xu, Ph.D.
Principal Scientist
Bhumesh
Savalia, M.Sc.
Principal Scientist
Zainab
Alali, Ph.D.
Director, Quality & Compliance
Jorge
Santiago-Ortiz, Ph.D.
Director, Process Development
Alex
Klarer
Head of Cell Therapy
Rucheet
Patel, M.Sc.
Project Manager
Dagmar
Meissner, M.Sc.
CMC Consultant
Mayank
Patel
Consultant
Amir
Varkouhi, MD, Ph.D.
Senior Research Fellow
John
Yarotsky, Ph.D.
Senior Research Fellow
Recent Updates
Choosing a CDMO: Top 10 Intangibles Biotech Firms Should Consider
October 22, 2020Virtual Ribbon Cutting of BioCentriq™ Scheduled for October 29th at 2:30pm
October 21, 2020Viral Vector Market Projected to Grow Exponentially, Increasing Demand for Skilled Workforce
October 14, 2020Cytiva’s Beth Thompson-Webb Joins BioCentriq’s Advisory Committee
June 9, 2020Get In Touch
Tell us about your next project or greatest challenge and we'll contact you to discuss how we can help. For more information about the Biopharma Division, click here.